Skip to content
Research Article Open access CC BY 4.0

Survival Times of Lung, Breast, Cervical, and Prostate Cancer Patients in Africa

Samuel Babajide Atoyebi

Journal of Cancer and Tumor International · pp. 9–28 · Published 28 Feb 2023

10.9734/jcti/2023/v13i1226

Abstract

Cancer is a leading cause of death and disability in Africa, and addressing this disease remains a significant challenge for many African countries. This paper examines the survival times of cancer in Africa through a critical review of 38 publications that comprise 27,795 samples with lung, breast, cervical, and prostate cancer. The overall survival time at one year was 77.4%, and the loco-regional rate of survival at three years was 71.8%. For cervical, breast, lung, and prostate cancer, the five-month survival time was 73.1-79.9%. The mean survival times for lung cancer patients at one year was 78.2%, and the mean annual survival times at three years was 52.8%. The mean age at the time of the study was 57.6 years. Total estimated pooled survival times for cancer patients in Africa was 60.66% (95% CI: 56.27, 65.06). And, the survival times of cancer patients in Southern Africa is 14.30%, 26.21% in Eastern Africa, 24.51% in Western Africa, and 41.06% in Central Africa. To improve survival times of lung, breast, cervical, and prostate cancer patients in Africa, it is important to increase awareness about cancer and its risk factors. And consortia should be promoted, whereby regions in Africa that have better resources can serve as mentors.

Survival times cervical cancer lung cancer breast cancer prostate cancer Africa

References (96)

  1. 1 Global cancer statistics [DOI]
  2. 2 Cancer statistics, 2014 [DOI]
  3. 3 Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries [DOI]
  4. 4 Global Cancer Incidence and Mortality Rates and Trends—An Update [DOI]
  5. 5 Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 [DOI]
  6. 6 The global burden of women’s cancers: a grand challenge in global health [DOI]
  7. 7 Triple-negative breast cancer in African-American women: disparities versus biology [DOI]
  8. 8 The CAG repeat within the androgen receptor gene and its relationship to prostate cancer [DOI]
  9. 9 Targeted therapy for non-small cell lung cancer: current standards and the promise of the future. [DOI]
  10. 10 The Impact of Study Size on Meta-analyses: Examination of Underpowered Studies in Cochrane Reviews [DOI]
  11. 11 Long-Term Results of the International Adjuvant Lung Cancer Trial Evaluating Adjuvant Cisplatin-Based Chemotherapy in Resected Lung Cancer [DOI]
  12. 12 Meta-Analysis of Survival in African American and White American Patients With Breast Cancer: Ethnicity Compared With Socioeconomic Status [DOI]
  13. 13 Evidence Supports a Faster Growth Rate and/or Earlier Transformation to Clinically Significant Prostate Cancer in Black Than in White American Men, and Influences Racial Progression and Mortality Disparity [DOI]
  14. 14 Demographic, knowledge, attitudinal, and accessibility factors associated with uptake of cervical cancer screening among women in a rural district of Tanzania: Three public policy implications [DOI]
  15. 15 Interventions to close the divide for women with breast and cervical cancer between low-income and middle-income countries and high-income countries [DOI]
  16. 16 Human papillomavirus prevalence and type distribution in invasive cervical cancer in sub‐Saharan Africa [DOI]
  17. 17 Epidemiology and Pathophysiology of Prostate Cancer in African-American Men [DOI]
  18. 18 Human papillomavirus infection and the primary and secondary prevention of cervical cancer [DOI]
  19. 19 Clinico-morphological patterns of breast cancer including family history in a New Delhi hospital, India-A cross-sectional study [DOI]
  20. 20 RACIAL/ETHNIC DISPARITIES IN THE TREATMENT OF LOCALIZED/REGIONAL PROSTATE CANCER [DOI]
  21. 21 Breast cancer early detection methods for low and middle income countries, a review of the evidence [DOI]
  22. 22 Racial and Ethnic Disparities in Early-Stage Lung Cancer Survival [DOI]
  23. 23 Is prostate cancer different in black men? Answers from 3 natural history models [DOI]
  24. 24 Cancer of childhood in sub-Saharan Africa [DOI]
  25. 25 Interplay of Race, Socioeconomic Status, and Treatment on Survival of Patients With Prostate Cancer [DOI]
  26. 26 Sociocultural Factors and Breast Cancer in Sub-Saharan Africa: Implications for Diagnosis and Management [DOI]
  27. 27 Ethnic Differences in Breast Cancer Survival: Status and Determinants [DOI]
  28. 28 Breast cancer survival experiences at a tertiary hospital in sub-Saharan Africa: a cohort study [DOI]
  29. 29 Racial Disparities in Oncologic Outcomes After Radical Prostatectomy: Long-term Follow-up [DOI]
  30. 30 Cervical cancer survival in a resource-limited setting-North Central Nigeria [DOI]
  31. 31 Cervical cancer patients presentation and survival in the only oncology referral hospital, Ethiopia: a retrospective cohort study [DOI]
  32. 32 Comparison of Prevalence and Types of Mutations in Lung Cancers Among Black and White Populations [DOI]
  33. 33 Racial Variations in Prostate Cancer Molecular Subtypes and Androgen Receptor Signaling Reflect Anatomic Tumor Location [DOI]
  34. 34 Incidence of cervical precancers among HIV-seropositive women [DOI]
  35. 35 Genetic polymorphism and prostate cancer aggressiveness: A case‐only study of 1,536 GWAS and candidate SNPs in African‐Americans and European‐Americans [DOI]
  36. 36 Human papillomavirus infection in women with and without cervical cancer in Ibadan, Nigeria [DOI]
  37. 37 Why the time is right to tackle breast and cervical cancer in low-resource settings [DOI]
  38. 38 African Breast Cancer—Disparities in Outcomes (ABC-DO): protocol of a multicountry mobile health prospective study of breast cancer survival in sub-Saharan Africa [DOI]
  39. 39 Breast cancer among women in sub-Saharan Africa: prevalence and a situational analysis [DOI]
  40. 40 Racial/ethnic differences in lifestyle-related factors and prostate cancer risk: the Multiethnic Cohort Study [DOI]
  41. 41 Breast Cancer Survival in Cameroon: Analysis of a Cohort of 404 Patients at the Yaoundé General Hospital [DOI]
  42. 42 Treatment options, selection, and satisfaction among african american and white men with prostate carcinoma in north carolina [DOI]
  43. 43 The four pillars of scholarly publishing: The future and a foundation [DOI]
  44. 44 Consanguinity Protecting Effect Against Breast Cancer among Tunisian Women: Analysis of BRCA1 Haplotypes [DOI]
  45. 45 Cervical cancer screening in developing countries [DOI]
  46. 46 Characteristics of cervical disease among symptomatic women with histopathological sample at Hawassa University referral hospital, Southern Ethiopia [DOI]
  47. 47 Smoking and prostate cancer survival and recurrence [DOI]
  48. 48 Incidence, mortality and survival from invasive cervical cancer in Vaud, Switzerland, 1974-1991 [DOI]
  49. 49 The Survival Of Patients With Cancer Of The Cervix In Nairobi, Kenya
  50. 50 How to conduct meta-analysis: a basic tutorial [DOI]
  51. 51 Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [DOI]
  52. 52 Global cancer statistics, 2012 [DOI]
  53. 53 Cancer statistics, 2020 [DOI]
  54. 54 Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods [DOI]
  55. 55 Cancer treatment and survivorship statistics, 2016 [DOI]
  56. 56 Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis [DOI]
  57. 57 Epidemiology of Prostate Cancer [DOI]
  58. 58 Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis [DOI]
  59. 59 HPV Vaccination and the Risk of Invasive Cervical Cancer [DOI]
  60. 60 Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis [DOI]
  61. 61 HIV-positive women have higher risk of human papilloma virus infection, precancerous lesions, and cervical cancer [DOI]
  62. 62 Breast cancer survival in sub‐Saharan Africa by age, stage at diagnosis and human development index: A population‐based registry study [DOI]
  63. 63 Use of Active Surveillance or Watchful Waiting for Low-Risk Prostate Cancer and Management Trends Across Risk Groups in the United States, 2010-2015 [DOI]
  64. 64 Evidence of synergistic relationships between HIV and Human Papillomavirus ( HPV ): systematic reviews and meta‐analyses of longitudinal studies of HPV acquisition and clearance by HIV status, and of HIV acquisition by HPV status [DOI]
  65. 65 Cervical cancer screening knowledge and barriers among women in Addis Ababa, Ethiopia [DOI]
  66. 66 Whole-Genome Sequencing Reveals Elevated Tumor Mutational Burden and Initiating Driver Mutations in African Men with Treatment-Naïve, High-Risk Prostate Cancer [DOI]
  67. 67 The Economic Effects of Brexit: Evidence from the Stock Market [DOI]
  68. 68 Impact of time-to-treatment on overall survival of non-small cell lung cancer patients—an analysis of the national cancer database [DOI]
  69. 69 An investigation of cancer survival inequalities associated with individual-level socio-economic status, area-level deprivation, and contextual effects, in a cancer patient cohort in England and Wales [DOI]
  70. 70 Cancer in Africa: Is It a Genetic or Environmental Health Problem? [DOI]
  71. 71 Time to death from cervical cancer and predictors among cervical cancer patients in Felege Hiwot Comprehensive Specialized Hospital, North West Ethiopia: Facility-based retrospective follow-up study [DOI]
  72. 72 Black Race is an Adverse Prognostic Factor for Prostate Cancer Recurrence Following Radical Prostatectomy in an Equal Access Health Care Setting [DOI]
  73. 73 META-ANALYSIS AS A RESEARCH TOOL: A SYSTEMATIC REVIEW OF BIBLIOMETRIC STUDIES IN ADMINISTRATION [DOI]
  74. 74 Tobacco biomarkers and genetic/epigenetic analysis to investigate ethnic/racial differences in lung cancer risk among smokers [DOI]
  75. 75 Human Papillomavirus and Cervical Cancer [DOI]
  76. 76 Prevalence of late-stage presentation and associated factors of cervical cancer patients in Tikur Anbesa Specialized Hospital, Ethiopia: institutional based cross-sectional study [DOI]
  77. 77 Prevalence of human papillomavirus genotypes in cervical cancer in Maiduguri, Nigeria [DOI]
  78. 78 Clinical Oncology Society of Australia position statement on exercise in cancer care [DOI]
  79. 79 Breast Cancer Survival in Eastern Region of Ghana [DOI]
  80. 80 Cervical cancer survival times in Africa [DOI]
  81. 81 Treatment outcomes and its associated factors among breast cancer patients at Kitui Referral Hospital [DOI]
  82. 82 Perceptions of first-year students in online lectures in the Covid-19 pandemic era viewed from learning motivation [DOI]
  83. 83 Survival analysis of Time to Death of Breast Cancer Patients: in case of Ayder Comprehensive Specialized Hospital Tigray, Ethiopia. [DOI]
  84. 84 The Impact of Breast Cancer Treatment Delays on Survival Among South African Women [DOI]
  85. 85 Do Technology-based Approaches Reduce Mathematics Anxiety? A Systematic Literature Review [DOI]
  86. 86 Risk of Cancer Death Among White, Black, and Hispanic Populations in South Florida [DOI]
  87. 87 Analysis of Genetic Alterations in Tunisian Patients with Lung Adenocarcinoma [DOI]
  88. 88 The Link between Mathematics Teaching Strategies and Students' Anxiety [DOI]
  89. 89 Prognostic factors for treatment response and survival outcomes after first-line management of Stage 4 non-small cell lung cancer: A real-world Indian perspective [DOI]
  90. 90 Relationship between West African ancestry with lung cancer risk and survival in African Americans [DOI]
  91. 91 The pathway to diagnosis and treatment for surgically managed lung cancer patients [DOI]
  92. 92 Determinants of Mortality among Cervical Cancer Patients Attending in Tikur Anbessa Specialized Hospital, Ethiopia: Institutional-Based Retrospective Study [DOI]
  93. 93 A Meta-analytic Review of the Relationship between Mathematics Anxiety and the Mathematical Thinking of Africa Students [DOI]
  94. 94 Prognostic Factors and Survival of Patients with Primitive Lung Cancer in Douala and Yaounde [DOI]
  95. 95 International Agency for Research on Cancer [DOI]
  96. 96 Breast cancer survival in rural sub-Saharan Africa [DOI]

Cited by 10

The Impact of Mathematics Anxiety on the Mathematical Value of Secondary School Students in Nigeria

Oluwatoyin Motunrayo Atoyebi, Samuel Babajide Atoyebi, Adeola Folasade Ajao · Asian Journal of Advanced Research and Reports · 2023

Survival status of women with cervical cancer in Sub-Saharan Africa: a systematic review and meta-analysis, 2024

Tadele Emagneneh, Chalie Mulugeta, Betelhem Ejigu · Frontiers in Oncology · 2025

Forecasting Currency in Circulation in Nigeria Using Holt-Winters Exponential Smoothing Method

Samuel Babajide Atoyebi, Matthew Femi Olayiwola, James Olasunkanmi Oladapo · South Asian Journal of Social Studies and Economics · 2023

Demographic and Population Determinants, and Consequences of Cancer Incidence and Survival in Nigeria

Omolara Aminat Fatiregun · Historical and Contemporary Demographic and Population Issues in Africa and South Asia · 2025

Showing 4 of 10 known citations — external sources report more than can currently be individually listed.

Article metrics

Real usage data collected on this platform.

36

Page views

0

PDF downloads

4

Outbound clicks

10

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.